Skip to content
HowShorted

ARROWHEAD PHARMACEUTICALS, INC. short interest in 2019

In 2019, ARROWHEAD PHARMACEUTICALS, INC.'s disclosed short interest ran from 18.91% of shares outstanding on 15 Jan 2019 to 11.66% on 31 Dec 2019, a change of -7.25 percentage points. The year's high was 20.19% on 31 May 2019 and its low 11.66% on 31 Dec 2019, averaging 16.64% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.03 days on 15 Jul 2019. Full history: ARROWHEAD PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ARROWHEAD PHARMACEUTICALS, INC. in 2019

2019 in figures

Start of year
18.91% (15 Jan 2019)
End of year
11.66% (31 Dec 2019)
Change
-7.25 pp
High
20.19% (31 May 2019)
Low
11.66% (31 Dec 2019)
Average
16.64%
Highest days to cover
19.03 (15 Jul 2019)
SEC filings marked
8

Every report in 2019

ARROWHEAD PHARMACEUTICALS, INC. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201918.91%9.34
31 Jan 201917.90%11.29
15 Feb 201917.09%7.3510-Q filed, results (8-K)
28 Feb 201917.64%10.12
15 Mar 201917.71%9.35
29 Mar 201916.67%12.39
15 Apr 201915.32%10.12
30 Apr 201915.03%13.04
15 May 201914.07%10.1310-Q filed, results (8-K)
31 May 201920.19%3.74
14 Jun 201918.44%10.77
28 Jun 201919.23%8.26
15 Jul 201919.71%19.03
31 Jul 201918.82%16.17
15 Aug 201916.56%14.9310-Q filed, results (8-K)
30 Aug 201916.91%10.45
13 Sep 201916.79%10.12
30 Sep 201916.80%10.75
15 Oct 201915.54%13.91
31 Oct 201915.56%8.91
15 Nov 201915.41%9.17
29 Nov 201914.66%4.7010-K filed, results (8-K)
13 Dec 201912.80%3.92
31 Dec 201911.66%3.64

See also: ARROWHEAD PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.